Biocon plans to introduce generic versions of the weight-loss drug Wegovy in India and Canada by 2027, according to CEO Siddharth Mittal.

Hengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

A major ICMR-led study reveals that 1 in 4 Indian married couples are overweight or obese, with urban, affluent, and media-exposed households showing the highest spousal weight concordance., Health, T ...

A viral claim circulating on social media alleges that the Health Ministry Issued Warnings on Samosa and Jalebi Like It Does ...

Since the onset of the COVID-19 pandemic, the prevalence of obesity in Canada has increased at a greater rate.

Reducing calories from ultra-processed foods, improving access to whole foods, and better understanding how these products ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

Experts have noted a concerning and mysterious rise in rates of bowel cancer among young adults, defined in cancer terms as ...

Carpal tunnel syndrome is twice as common in the 2 or more years preceding a diagnosis of rheumatoid arthritis, according to ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

The Ohio Department of Administrative Services announced state employees’ Medicaid coverage for GLP-1 obesity management ...